Hematology - Medical Oncology Clinical Trials Resources
Listed below are the Hematology - Medical Oncology Clinical Trials offered at the Kaiser Permanente Santa Clara Medical Center.
| Title: | Phase 3, Randomized, Open Label Trial of Lenalidomide/Dexamethasone With or Without Elotuzumab in Relapsed or Refractory Multiple Myeloma (ELOQUENT - 2) |
|---|---|
| Phase: | III |
| Protocol Number: | CA204-004 |
| Sponsors and Collaborators: | Bristol-Myers Squibb (BMS) |
| Weblink: | Link to Clinical Trial |
| Title: | A RANDOMIZED PHASE III TRIAL OF CC-5013 (LENALIDOMIDE, NSC-703813) AND LOW DOSE DEXAMETHASONE (LLD) VERSUS BORTEZOMIB (PS-341, NSC-681239), LENALIDOMIDE AND LOW DOSE DEXAMETHASONE (BLLD) FOR INDUCTION, IN PATIENTS WITH PREVIOUSLY UNTREATED MULTIPLE MYELOMA WITHOUT AN INTENT FOR IMMEDIATE AUTOLOGOUS STEM CELL TRANSPLANT. |
|---|---|
| Phase: | III |
| Protocol Number: | S0777 |
| Sponsors and Collaborators: | Southwest Oncology Group (SWOG) |
| Weblink: | Link to Clinical Trial |
| Title: | Allogeneic HCT Using Nonmyeloablative Host Conditioning With TLI & ATG vs SOC in AML |
|---|---|
| Phase: | III |
| Protocol Number: | Stanford AML |
| Sponsors and Collaborators: | Stanford |
| Weblink: | Link to Clinical Trial |
ONGOING STUDIES ONLY CLOSED FOR NEW PARTICIPANTS
| Title: | DASATINIB IN CHRONIC MYELOGENOUS LEUKEMIA OR PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIC SUBJECTS WHO ARE EXPERIENCING CLINICAL BENEFIT ON CURRENT START PROTOCOLS: LONG TERM SAFETY AND EFFICACY ANALYSIS. |
|---|---|
| Phase: | N/A |
| Protocol Number: | CA180-188 |
| Sponsors and Collaborators: | Bristol-Myers Squibb (BMS) |
| Weblink: | Link to Clinical Trial |
| Title: | STUDY OF BONE MARROW AND BLOOD SAMPLES FROM PATIENTS WITH LEUKEMIA OR OTHER HEMATOPOIETIC CANCERS. |
|---|---|
| Phase: | Observational |
| Protocol Number: | S9007 |
| Sponsors and Collaborators: | Southwest Oncology Group (SWOG) |
| Weblink: | Link to Clinical Trial |
